Vir Biotechnology Inc (VIR)
9.72
-0.21
(-2.11%)
USD |
NASDAQ |
May 17, 16:00
9.72
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -107.93M |
| September 30, 2023 | -155.83M |
| June 30, 2023 | -389.25M |
| March 31, 2023 | -125.78M |
| December 31, 2022 | 35.13M |
| September 30, 2022 | 117.90M |
| June 30, 2022 | 960.14M |
| March 31, 2022 | 550.09M |
| December 31, 2021 | 7.695M |
| September 30, 2021 | -105.81M |
| Date | Value |
|---|---|
| June 30, 2021 | 140.06M |
| March 31, 2021 | -89.53M |
| December 31, 2020 | -82.05M |
| September 30, 2020 | -49.84M |
| June 30, 2020 | -10.64M |
| March 31, 2020 | -48.41M |
| December 31, 2019 | -38.88M |
| September 30, 2019 | -36.96M |
| June 30, 2019 | -24.30M |
| March 31, 2019 | -29.49M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-389.25M
Minimum
Jun 2023
960.14M
Maximum
Jun 2022
28.73M
Average
-38.88M
Median
Dec 2019
Cash from Operations (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 1.307B |
| SeaStar Medical Holding Corp | -4.485M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -800.36M |
| Free Cash Flow Per Share (Quarterly) | -0.8132 |
| Free Cash Flow to Equity (Quarterly) | -109.46M |
| Free Cash Flow to Firm (Quarterly) | -109.46M |
| Free Cash Flow Yield | -61.13% |